Citadel Advisors »

Sionna Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Sionna Therapeutics (SION) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Sionna Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sionna Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sionna Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.1M 36k 29.41
2025-06-30 $2.3M 130k 17.35
2025-03-31 $3.4M 327k 10.46

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
Strategy Cl A New Call Option (MSTR)
Alphabet Cap Stk Cl A Call Option (GOOGL)
UnitedHealth Call Option (UNH)
Palantir Technologies Cl A Call Option (PLTR)
Netflix Call Option (NFLX)

View all positions for Citadel Advisors

Top funds holding Sionna Therapeutics

RA Capital Management
Tpg Gp A
OrbiMed Advisors
Atlas Venture Life Science Advisors
Viking Global Investors
Enavate Sciences GP
Jpmorgan Chase & Co
Perceptive Advisors
Vanguard Group
Jennison Associates
Deerfield Management Company
Standard Life Aberdeen
BlackRock
Soleus Capital Management
Baker Bros. Advisors

View all funds holding Sionna Therapeutics